Michael L Cheng

Michael L Cheng

UNVERIFIED PROFILE

Are you Michael L Cheng?   Register this Author

Register author
Michael L Cheng

Michael L Cheng

Publications by authors named "Michael L Cheng"

Are you Michael L Cheng?   Register this Author

17Publications

327Reads

9Profile Views

Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas.

Lung Cancer 2019 Dec 16;140:35-41. Epub 2019 Dec 16.

Department of Pathology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.12.005DOI Listing
December 2019

Does TMB Impact the Effectiveness of TKIs in -Mutant NSCLC?

Clin Cancer Res 2019 02 6;25(3):899-900. Epub 2018 Sep 6.

Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-2368DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359945PMC
February 2019

Clinical tumour sequencing for precision oncology: time for a universal strategy.

Nat Rev Cancer 2018 09;18(9):527-528

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41568-018-0043-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618305PMC
September 2018

Novel biomarkers in bladder cancer.

Urol Oncol 2018 03 19;36(3):115-119. Epub 2018 Feb 19.

Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Weill Cornell Medical College, New York, NY. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2018.01.009DOI Listing
March 2018

Opportunities and Challenges in Genomic Sequencing for Precision Cancer Care.

Ann Intern Med 2018 02 9;168(3):221-222. Epub 2018 Jan 9.

Memorial Sloan Kettering Cancer Center, New York, New York (D.B.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/M17-2940DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659420PMC
February 2018

The incidence of oesophageal cancer in Eastern Africa: identification of a new geographic hot spot?

Cancer Epidemiol 2015 Apr 3;39(2):143-9. Epub 2015 Feb 3.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2015.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470609PMC
April 2015

Beyond sipuleucel-T: immune approaches to treating prostate cancer.

Curr Treat Options Oncol 2014 Mar;15(1):115-26

University of California San Francisco, 513 Parnassus Ave., Box 0511, San Francisco, CA, 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-013-0267-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523381PMC
March 2014

Effects of RANKL-Targeted Therapy in Immunity and Cancer.

Front Oncol 2014 Jan 7;3:329. Epub 2014 Jan 7.

Division of Hematology and Oncology, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco , San Francisco, CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882875PMC
January 2014

Abiraterone acetate for the treatment of prostate cancer.

Expert Opin Pharmacother 2013 Jan 30;14(1):91-6. Epub 2012 Nov 30.

Genitourinary Medical Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2013.745852DOI Listing
January 2013